申请人:Merck & Co., Inc.
公开号:US04242344A1
公开(公告)日:1980-12-30
Piperazinyl-imidazo[1,2-a]pyrazines, derived from reactions between halo-imidazo[1,2-a]pyrazines with piperazine derivatives, are found to be active anorexic, antidepressant, antihypertensive, analgesic, antiarrhythmic, and/or anti-smoking agents.
从卤代咪唑[1,2-a]吡嗪与哌嗪衍生物反应而得的哌嗪基咪唑[1,2-a]吡嗪,被发现具有活性,可用作厌食症、抗抑郁、降压、镇痛、抗心律失常和/或戒烟药剂。